The Senate Judiciary Committee on Thursday (May 24) voted to send five opioid-related bills to the Senate floor, including a measure that would require the Drug Enforcement Administration (DEA) to consider diversion, abuse and other public health impacts of opioids when setting annual production quotas for manufacturers. The committee also passed another bill that would provide drug manufacturers and distributors access to DEA data on opioid orders. Committee Chair Chuck Grassley (R-IA) chose to hold one of the bills, “Preventing...